Sunnyside Care Center | |
16561 Us Highway 10, Lake Park, Minnesota 56554 | |
(218) 238-5944 | |
Name | Sunnyside Care Center |
---|---|
Location | 16561 Us Highway 10, Lake Park, Minnesota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 30 |
Occupancy Rate | 61.67% |
Medicare ID (CCN) | 245597 |
Legal Business Name | Sunnyside Nursing Home |
Ownership Type | Government - County |
NPI Number | 1831126374 |
Organization Name | SUNNYSIDE NURSING HOME |
Doing Business As | SUNNYSIDE CARE CENTER |
Address | 16561 Us Highway 10, Lake Park, MN 56554 |
Phone Number | 218-238-5944 |
News Archive
Because of the very high costs in developing drugs for rare genetic diseases, and the low return on investment, the pharmaceutical industry has rarely developed specific treatments for many of these diseases.
C2 Health, a division of C2 Technologies, Inc., announced today the launch of its Health Exchange Learning Portal (HELP) at C2-Health.com, a complete suite of classroom, eLearning courses, and resources for nationwide education of Navigators/Consumer Assistors, Consumers, Brokers, Call Center Representatives (CSRs), Health Workers and Volunteers tasked with helping consumers enroll for healthcare coverage under the Affordable Care Act of 2010 (ACA).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that U.S. gastroenterologists will treat a larger proportion of treatment nonresponder hepatitis C patients with Vertex/Tibotec/Mitsubishi Tanabe's telaprevir than Merck's boceprevir.
Now, a new preprint research paper posted to the bioRxiv server reports the development of a modified mouse model that allows productive SARS-CoV-2 infection of the mouse lungs, as well as the exploration of type I and III interferon responses in this condition.
Announcing a new article publication for BIO Integration journal. In this commentary article the authors Phei Er Saw and Shanping Jiang from Sun Yat-sen University, Guangzhou, People's Republic of China consider the significance of interdisciplinary integration in academic research and application.
› Verified 7 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Because of the very high costs in developing drugs for rare genetic diseases, and the low return on investment, the pharmaceutical industry has rarely developed specific treatments for many of these diseases.
C2 Health, a division of C2 Technologies, Inc., announced today the launch of its Health Exchange Learning Portal (HELP) at C2-Health.com, a complete suite of classroom, eLearning courses, and resources for nationwide education of Navigators/Consumer Assistors, Consumers, Brokers, Call Center Representatives (CSRs), Health Workers and Volunteers tasked with helping consumers enroll for healthcare coverage under the Affordable Care Act of 2010 (ACA).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that U.S. gastroenterologists will treat a larger proportion of treatment nonresponder hepatitis C patients with Vertex/Tibotec/Mitsubishi Tanabe's telaprevir than Merck's boceprevir.
Now, a new preprint research paper posted to the bioRxiv server reports the development of a modified mouse model that allows productive SARS-CoV-2 infection of the mouse lungs, as well as the exploration of type I and III interferon responses in this condition.
Announcing a new article publication for BIO Integration journal. In this commentary article the authors Phei Er Saw and Shanping Jiang from Sun Yat-sen University, Guangzhou, People's Republic of China consider the significance of interdisciplinary integration in academic research and application.
› Verified 7 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 19.23 | 14.46 |
Percentage of long-stay residents who lose too much weight | 2.44 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 40.48 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.6 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.38 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 11.84 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.3 | 83.88 |